E642-0682 Screening compound: 4-[({3-[(4-methoxyphenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]-N-(propan-2-yl)benzamide

E642-0682 Screening compound: 4-[({3-[(4-methoxyphenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]-N-(propan-2-yl)benzamide
E642-0682 Screening compound: 4-[({3-[(4-methoxyphenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]-N-(propan-2-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E642-0682
4-[({3-[(4-methoxyphenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]-N-(propan-2-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E642-0682

Molecular Formula

C25H26N4O2S (C25 H26 N4 O2 S)

Compound Name

4-[({3-[(4-methoxyphenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]-N-(propan-2-yl)benzamide

IUPAC name

4-[({3-[(4-methoxyphenyl)methyl]-3H-imidazo[45-b]pyridin-2-yl}sulfanyl)methyl]-N-(propan-2-yl)benzamide

SMILES

CC(C)NC(c1ccc(CSc(n2Cc(cc3)ccc3OC)nc3c2nccc3)cc1)=O

InChI

InChI=1S/C25H26N4O2S/c1-17(2)27-24(30)20-10-6-19(7-11-20)16-32-25-28-22-5-4-14-26-23(22)29(25)15-18-8-12-21(31-3)13-9-18/h4-14,17H,15-16H2,1-3H3,(H,27,30)

InChI Key

NEEQCRRVLRUAOC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14906701

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.162

Distribution Coefficient, logD

4.161

Water Solubility, LogSw

-4.11

Polar Surface Area

51.587

Acid Dissociation Constant (pKa)

13.93

Base Dissociation Constant (pKb)

4.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

E642-0682 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anticancer Library (62698 compounds)

GABA Library (7115 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Regenerative Medicine Focused Library (23016 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
  • Ion Channels
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E642-0682 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E642-0682?
Check Price and Availability of E642-0682, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E642-0682 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E642-0682
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E642-0682
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E642-0682 available by request